MVA-PP (Modified Virus Ankara polyprotein)

BIOLOGICAL2 trials

Sponsors

European Vaccine Initiative

Conditions

MalariaMalaria, Falciparum

Phase 1

Sporozoite Challenge of Polyprotein Vaccinees

CompletedNCT00375128

European Vaccine InitiativeMalaria, Malaria, Falciparum

Start: 2006-09-30End: 2007-04-30Target: 26Updated: 2007-10-19

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

CompletedNCT00374998

European Vaccine InitiativeMalaria, Malaria, Falciparum

Start: 2006-04-30End: 2007-01-31Target: 35Updated: 2007-03-01